Nadir Mahmood

Companies

• Nkarta Therapeutics (United States)President Jul 31, 2024 to now¹
• Nkarta Therapeutics (United States)Chief Business Officer Jul 9, 2020 to Jun 22, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNkarta Therapeutics (United States) NKTX167,727 shares³$299.4K at $1.78Jan 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 15, 2026Sold 5,649 shares at $2.07 of Nkarta Therapeutics (United States)³
• Jan 6, 2026Granted 80,000 shares of Nkarta Therapeutics (United States)⁴
• Jan 3, 2025Granted 62,000 shares of Nkarta Therapeutics (United States)⁵
• Jun 20, 2023Sold 526 shares at $4.85 of Nkarta Therapeutics (United States)⁶
• Jan 17, 2023Sold 1,122 shares at $5.49 of Nkarta Therapeutics (United States)⁷
• Jan 13, 2023Granted 37,500 shares of Nkarta Therapeutics (United States)⁷
• Aug 15, 2022Sold 7,500 shares at $18.03 of Nkarta Therapeutics (United States)⁸
• Aug 15, 2022Exercised options 7,500 shares at $3.89 of Nkarta Therapeutics (United States)⁸
• Aug 8, 2022Sold 7,500 shares at $15.32 of Nkarta Therapeutics (United States)⁹
• Aug 8, 2022Exercised options 7,500 shares at $3.89 of Nkarta Therapeutics (United States)⁹
• Jul 25, 2022Sold 7,500 shares at $13.40 of Nkarta Therapeutics (United States)¹⁰
• Jul 25, 2022Exercised options 7,500 shares at $3.89 of Nkarta Therapeutics (United States)¹⁰
• Jun 17, 2022Granted 6,000 shares of Nkarta Therapeutics (United States)¹¹
• Jan 14, 2022Granted 12,800 shares of Nkarta Therapeutics (United States)¹²